Last updated: March 28, 2022
Sponsor: Tsinghua University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Scleroderma
Scar Tissue
Collagen Vascular Diseases
Treatment
N/AClinical Study ID
NCT05297474
12040740374
Ages 18-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Clinical diagnosis of systemic sclerosis
Exclusion
Exclusion Criteria: Complicated with other immune disease Claustrophobia Contraindications for MR examinationHeart or respiratory failure Diseases that affect MR findings (e.g. rapid atrialfibrillation) Complicated with heart, brain and kidney diseases not caused by SSc(such asdiabetic nephropathy and congenital heart disease) Pregnant Disturbance of consciousness
Study Design
Total Participants: 95
Study Start date:
July 01, 2021
Estimated Completion Date:
December 01, 2022
Study Description
Connect with a study center
China Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University
Beijing, 100084
ChinaActive - Recruiting
Huilin He
Beijing, 100032
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.